leisure time -WSS

leisure time

author：entertainment 2025-09-28 02:33:14 - browse：4

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Medicare reduced heart disease by changing how it pays doctors

WSS

Medicare reduced heart disease by changing how it pays doctors

Medicare reduced heart disease by changing how it pays doctors

FDA gives detailed accounting of AI

Methadone treatment changes are coming. Do they go far enough?

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Gene editing the human germline: What are the risks?

Wikipedia

leisure time

leisure time

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

The high cost of giving birth even with insurance

Positive childhood experiences can help future health

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Will Ozempic

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Stop the failed accountable care organization experiment

Moonlake's readout produced a cash windfall. Risks remain

UnitedHealth increases loan offers after Change Healthcare outage

Wikipedia

Gene editing the human germline: What are the risks?

FDA warns J&J's Abiomed: We will regulate your software

FDA gives detailed accounting of AI

HHS leader on health, climate change and biopharma emissions

Lawmakers consider Medicare pay reforms for doctors

Positive childhood experiences can help future health

leisure time

entertainment

focus

entertainment